Investing and innovating in ways that break through cost, quality and access barriers to health for individuals and entire health systems, GE Healthcare is highlighting an advanced portfolio of molecular imaging technologies at the 58th annual meeting of the Society of Nuclear Medicine (SNM), June 4-8, in San Antonio.
"At GE Healthcare we are committed to developing products that increase access to life saving technologies, improve the quality of healthcare that patients receive, and do it in a cost effective way for our customers," said Terri Bresenham, vice president and general manager Molecular Imaging, GE Healthcare. "Healthcare touches everyone. That's why GE is committed to helping healthcare consumers and providers take on the world's greatest healthcare challenges through healthymagination: the company's six-year, $6 billion strategy to provide better health for more people at lower cost."
Discovery NM 630---fully upgradeable to SPECT/CT---addresses need for high quality technology that is more accessible
"More effective technology means more lives can be touched," said Nathan Hermony, general manager, Nuclear Medicine, GE Healthcare. "The new GE Healthcare system touches patient's lives in many ways. For example, the system is designed to allow patient doses as low as 50 percent those of standard nuclear medicine scanning protocols, or the potential for patients to spend significantly less time on the table during exams, all without compromising image quality."
The Discovery NM630 is engineered to help accommodate more patients than previous generation GE nuclear medicine systems. With its large 28" (70cm) wide bore and table capable of handling patients up to 500lbs. (227 kilograms), the Discovery NM630 provides access to a wide variety of patient sizes.
The more precise the information healthcare providers can get about a patient's condition, the more effectively that patient can be treated. A step forward in detector design, the Elite NXT detector enables exceptional image quality. Elite NXT detectors are designed to offer outstanding SPECT resolution and exceptional contrast for superb image quality, all to help clinicians diagnose patients earlier and more accurately. The Discovery NM630 is 510(k) pending at the FDA. It is not available for sale in the U.S.
Award winning Optima PET/CT 560 provides performance, value and patient friendly experience
Recently receiving the 'Price Performance Value' Leadership Award in PET/CT for North America 2011 by global research firm, Frost & Sullivan, GE Healthcare's Optima PET/CT 560 is an innovative scanner designed to address the demands of today's healthcare environment. Combining superb image quality, high productivity and a patient friendly experience, the Optima PECT/CT 560 can continuously deliver ongoing value over time. The system offers efficiency and investment protection with the capability to grow with the future needs of the clinical practice. From the uninterrupted full head to toe exam to the remarkable dose reduction features, the Optima PET/CT 560 was designed to help physicians put patients' needs first. It includes advanced VUE Point HD intelligent 3D iterative reconstruction technique to enhance resolution for uncompromised image quality that can help enable clinicians to confidently detect small lesions and increase quantitative accuracy.
ASiR now available on Discovery NM/CT 670, Discovery PET/CT 600 and Discovery PET/CT 690
GE Healthcare is showcasing the advanced technique of Adaptive Statistical Iterative Reconstruction (ASiR†). With this innovation now available across the Discovery PET/CT and Discovery NM/CT product lines, clinicians don't have to compromise image quality while reducing dose to their patients. With over 500 installations and 6 million patient scans, ASIR is a proven CT technique to help decrease radiation dose.
Tri-Modality Imaging: PET/CT+MR
"In keeping with GE's healthymagination initiative of reducing cost, increasing access to healthcare and improving quality, our approach to PET/CT+MR is to harness the power of two proven technologies to provide researchers the high quality clinical information they expect and are accustomed to receiving," said Vivek Bhatt, general manager of the PET/CT business, GE Healthcare.
Top minds in multiple sclerosis to speak at CMSC 38th Annual Meeting